An estimated 250,000 intravascular device-related bloodstream infections occur in the United States every year.
Patients using tunneled hemodialysis catheters have an annualized 91% risk of acquiring a catheter-related bloodstream infection (CRBSI).
Each CRBSI event results in a 7-10 day hospitalization and cost $22,000. In the United States this totals $2B in direct cost, and that's only for patients using tunneled hemodialysis catheters.
Copyright © 2020 NitriCap Medical Inc. - All Rights Reserved.